Jens Kurth, PhD

Associate Partner

Jens is a biotech and pharma executive who has advanced scientific innovation, built companies and formed strategic partnerships across global markets.

Expertise

Global development of biologics and advanced therapies
Biotech company building and venture fundraising
Translational development and CMC strategy
Licensing, strategic partnerships and alliance management
Regulatory strategy (FDA, EMA, PMDA and others)
Global project and cross-functional leadership

Experience

Co-founded Vivet, Anokion and Cimeio and held executive roles at other biotech companies; worked across biologics, cell and gene therapies and raised more than €100 million in venture capital
Led strategic planning, fundraising, investor relations, licensing transactions and partnerships with major pharmaceutical companies
Novartis, Basel and Tokyo: senior roles in Biologics and Gene & Cell Therapy; led regulatory submissions across regions and cross-functional teams
Baxter, Vienna: led Technology Development and a 60-person Pilot Plant team; CMC and operational leadership contributed to €80 million in revenue growth in the first year

Education

Diploma and PhD in Biochemistry and Molecular Genetics, University of Cologne
Postdoctoral Fellow in Neuroscience and Comparative Medicine, Johns Hopkins University, Baltimore (1992–1997)